Ch. 4 part. 2 Flashcards
Coagulation cascade
amplifying enzyme conversions culminating in thrombin formation
Thrombin
most important coagulation factor. converts fibrinogen to fibrin (fibrin gel). Proinflammatory.
2 standard coagulation pathway assays
Prothrombin time (PT) and Partial Thromboplastin time (PTT)
Prothrombin time (PT) assay
Extrinsic pathway protein function. Factors 2, 5, 7, 10, and fibrinogen.
PT assay accomplished how?
adding tissue factor and phospholipids to citrated plasma (want to prevent spontaneous clotting). adding exogenous calcium.
Partial Thromboplastin time (PTT) assay
Intrinsic pathway protein function. Factors 2, 5, 8-12, and fibrinogen.
How is PTT assay initiated?
By addition of negatively charged particles (activate factor 12, hagemans)
Protease Activated Receptors (PARs)
mechanism of thrombin effects.
3 categories of endogenous anticoagulants
antithrombins (antithrombin III), Protein C and S, TFPI
Antithrombin (antithrombin III)
inhibit thrombin and factors 9-12a. Activated by binding heparin-like molecules.
Protein C and S
Vitamin K-dependent. inhibit factors 5a and 8a.
TFPI
produced by endothelium. inhibits tissue factor 7a.
3 primary abnormalities that lead to thrombosis (Virchow’s triangle)
Endothelial injury, turbulence/stasis, hypercoagulability
Endothelial cell injury
Cardiac chambers (after MI), ulcerated plaques, vasculitis
Insults of endothelial injury
Hypertension, turbulence, bacterial endotoxin, radiation, metabolic abnormalities, toxicity smoke
Turbulence
countercurrents or pockets of stasis.
stasis and turbulence promote
pro-coagulation by bringing platelets in contact to epithelium.
Hypercoagulability
thrombophilia. any alteration of coagulation that predisposes thrombosis.
Primary hypercoagulability (genetic) gene locations
Point mutations at Factor 5 and prothrombin genes.
primary hypercoag cause
elevated levels of homocysteine. (thioester linkages- thrombic), deficiency of antithrombin III, protein C or S.
Clinical presentation of primary hypercoag
venous thrombosis, recurrent thromboembolism
Heparin-induced thrombocytopenia (HIT) syndrome occurs when?
following the administration of unfractionated herparin, which induces Ab production to recognize complexes of heparin and platelet factor 4 (and like molecules)
Effects of HIT syndrome
causes platelet activation, aggregation, and consumption leading to thrombocytopenia (hence the name)
Antiphospholipid antibody syndrome (or lupus anticoagulant syndrome) clinical manifestations
recurrent thrombosis, miscarriages, cardiac valve vegetations, thrombocytopenia, pulmonary hypertension, pulmonary embolism, etc.. has primary and secondary forms.